Home / Products / Knockout Cell Lines

Knockout Cell Lines

Knockout cell lines provide defined loss-of-function models for studying gene activity in a controlled cellular background. By removing or disrupting a specific gene, researchers can directly evaluate its contribution to signaling pathways, disease phenotypes, drug sensitivity, cell growth, immune response, metabolism, differentiation, and other biological processes. As a key group of genome-edited cell lines, knockout cell lines are widely used in target validation, mechanism-of-action studies, functional screening, biomarker research, and disease model development.

Ascent Research offers CRISPR knockout cell lines across a range of commonly used mammalian cell line backgrounds. Our CRISPR KO cell line products are mainly generated using CRISPR RNP-based editing, in which Cas9 protein and guide RNA are delivered directly into cells. This non-viral strategy supports efficient gene disruption while avoiding unnecessary vector-based integration. Edited regions are typically confirmed by Sanger sequencing to verify the presence of target-site mutations and support reliable downstream use.

This category includes both clonal knockout cell lines and polyclonal KO cell pools. Clonal knockout cell lines are suitable when researchers require a more uniform genetic background and stable performance across repeated experiments. Polyclonal knockout cells, also called KO cell pools, provide a more economical option for early-stage screening, assay setup, pathway exploration, or projects where a mixed edited population is acceptable. These cell pools can help reduce cost and shorten project timelines before moving into single-cell clone selection.

In addition to standard knockout cell line products, Ascent Research supports custom cell line development for gene-specific knockout projects. Researchers can select host cell backgrounds based on disease relevance, pathway activity, assay compatibility, or comparison with parental and isogenic cell lines. Whether you need a knockout cell line for focused gene function research or multiple KO cell lines for broader screening applications, our engineered cell lines provide practical in vitro models for investigating gene loss and its biological consequences.

Showing 12 of 41685 results

TRIM2 Knockout A549 Cell Line

The TRIM2 Knockout A549 Cell Line is a CRISPR/Cas9-edited knockout model derived from human lung adenocarcinoma A549 cells, designed to disrupt the E3 ubiquitin ligase…
Cat. No. ARG44188

TRIB3 Knockout Hep-G2 Cell Line

The TRIB3 Knockout Hep-G2 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from human hepatocellular carcinoma Hep-G2 cells, offering a loss-of-function model for the…
Cat. No. ARG44187

TRAP1 Knockout HK-2 Cell Line

The TRAP1 Knockout HK-2 Cell Line offers a CRISPR/Cas9-edited, loss-of-function model in the HK-2 human kidney proximal tubule epithelial cell line. It enables targeted study…
Cat. No. ARG44186

Trap1 Knockout TCMK1 Cell Line

The Trap1 Knockout TCMK1 Cell Line is a CRISPR/Cas9-edited mouse kidney epithelial cell model with targeted disruption of the Trap1 gene. Trap1, a mitochondrial HSP90…
Cat. No. ARG44185

TRAF6 Knockout SW1353 Cell Line

The TRAF6 Knockout SW1353 Cell Line is a CRISPR/Cas9-edited human chondrosarcoma cell line with a disrupted TRAF6 gene. TRAF6 is an E3 ubiquitin ligase that…
Cat. No. ARG44184

TRAF6 Knockout IPEC-J2 Cell Line

The TRAF6 Knockout IPEC-J2 Cell Line is a genetically disrupted porcine intestinal epithelial cell model, created via CRISPR/Cas9, for investigating innate immune signaling. TRAF6 functions…
Cat. No. ARG44183

Tpt1 Knockout CT26.WT Cell Line

The Tpt1 Knockout CT26.WT Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the murine CT26.WT colorectal carcinoma model. It features targeted disruption of…
Cat. No. ARG44182

TPH1 Knockout HK-2 Cell Line

The TPH1 Knockout HK-2 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from human proximal tubule HK-2 cells, engineered to disrupt the TPH1 gene.…
Cat. No. ARG44181

TP53 Knockout T98G Cell Line

The TP53 Knockout T98G Cell Line is a CRISPR/Cas9-edited knockout line derived from human T98G glioblastoma cells. It disrupts the tumor suppressor TP53, which transcriptionally…
Cat. No. ARG44180

TP53 Knockout Marc-145 Cell Line

The TP53 Knockout Marc-145 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the African green monkey kidney epithelial Marc-145 line. TP53 encodes the…
Cat. No. ARG44179

TP53 Knockout PC-9 Cell Line

The TP53 Knockout PC-9 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from PC-9 human lung adenocarcinoma cells with targeted disruption of the TP53…
Cat. No. ARG44178

TOLLIP Knockout KYSE-150 Cell Line

The TOLLIP Knockout KYSE-150 Cell Line is a CRISPR/Cas9-edited knockout cell line based on the human esophageal squamous cell carcinoma line KYSE-150. This model disrupts…
Cat. No. ARG44177

Loading products...